APA (7th ed.) Citation

F, G., AB, H., CC, B., K, G., & HC, M. (2026). Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia. Vaccine, 86, 128731. https://doi.org/10.1016/j.vaccine.2026.128731

Chicago Style (17th ed.) Citation

F, Giannini, Hogan AB, Blyth CC, Glass K, and Moore HC. "Modelling the Impact of Long-acting Monoclonal Antibody, Maternal Vaccine and Hybrid Programs of RSV Immunisation in Temperate Western Australia." Vaccine 86 (2026): 128731. https://doi.org/10.1016/j.vaccine.2026.128731.

MLA (9th ed.) Citation

F, Giannini, et al. "Modelling the Impact of Long-acting Monoclonal Antibody, Maternal Vaccine and Hybrid Programs of RSV Immunisation in Temperate Western Australia." Vaccine, vol. 86, 2026, p. 128731, https://doi.org/10.1016/j.vaccine.2026.128731.